EBR Systems Q3 10-Q: Going-Concern Warning With $41.8M of Debt Due Within a Year
EBRCZ is trading near its 52-week low of $0.083 (0.1% above the low) on elevated volume (1.9× avg).
Summary
EBR Systems posted a $51.2 million nine-month loss and $54.7 million of operating cash burn, and disclosed substantial doubt about its ability to continue as a going concern with $41.8 million of debt due within twelve months.
Key Events · Earnings and Guidance · EBRCZ
-
Going-Concern Warning Disclosed
Substantial doubt now exists about the company's ability to continue as a going concern for at least twelve months from the filing date, based on expected operating losses, negative operating cash flows, and $41.8 million of debt obligations due within the next twelve months.
-
Nine-Month Loss Widens to $51.2M
For the nine months ended September 30, 2026, the net loss reached $51.2 million versus $34.7 million a year earlier, driven by SG&A up 92.8% to $29.9 million and R&D up 12.0% to $19.7 million.
-
Cash Burn of $54.7M
Operating activities used $54.7 million of net cash for the nine months, versus $38.2 million a year earlier. Cash, cash equivalents and marketable securities stood at $93.2 million at September 30, 2026, up from $54.2 million at December 31, 2025 after roughly $105.3 million of gross equity proceeds.
-
Debt Covenant and Maturity Risk
The $41.8 million Runway Growth term loan matures June 15, 2027 and is now classified as current. Compliance held at September 30, 2026, but the company warns liquidity could fall below the $2.5 million covenant requirement within twelve months.
Analysis · EBRCZ · Industrial Applications And Services
The quarterly report carries an explicit going-concern warning, and the reason is straightforward: EBR lost $51.2 million in the first nine months of 2026, burned $54.7 million of cash from operations, and faces $41.8 million of Runway Growth debt maturing June 15, 2027 — inside the next twelve months. Cash and marketable securities of $93.2 million are real, but management says it will need to raise more equity or debt, and it flags that liquidity could fall below the $2.5 million required under its debt covenant. Commercial traction is improving, with net sales of $7.5 million for the nine months versus $0.7 million a year ago and 127 implants at 41 U.S. hospitals, yet gross margin is only 10.4% and the sales build is what drives the cash burn. With the stock near its 52-week low, any new equity raise would be expensive.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EBRCZ was trading at $0.08 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $64.6M. The 52-week trading range was $0.08 to $1.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.